 |
1GWQ |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1GWR |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1L2I |
Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MVC |
Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MZN |
CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1NRL |
Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1OSV |
STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T73 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T74 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T76 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T79 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7F |
Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7M |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7R |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3R |
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3S |
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U9E |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X76 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X78 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7B |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7J |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1XIU |
Crystal structure of the agonist-bound ligand-binding domain of Biomphalaria glabrata RXR |
F |
B |
|
|
 |
1YMT |
Mouse SF-1 LBD |
B |
A |
|
|
 |
1YYE |
Crystal structure of estrogen receptor beta complexed with way-202196 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1ZAF |
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one |
C |
A |
|
|
 |
1ZDT |
The Crystal Structure of Human Steroidogenic Factor-1 |
Q |
B |
|
|
 |
1ZDU |
The Crystal Structure of Human Liver Receptor Homologue-1 |
Q |
A |
|
|
 |
2BJ4 |
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST |
C |
A |
|
|
 |
2GPO |
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2GTK |
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7Y |
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2JF9 |
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST |
P |
AC |
|
|
 |
2NV7 |
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2OVH |
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2Q3Y |
Ancestral Corticiod Receptor in Complex with DOC |
B |
A |
|
|
 |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CS8 |
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CWD |
Molecular recognition of nitro-fatty acids by PPAR gamma |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3D24 |
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3DCT |
FXR with SRC1 and GW4064 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3E7C |
Glucocorticoid Receptor LBD bound to GSK866 |
D |
B |
|
|
 |
3ERD |
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3F7D |
SF-1 LBD bound by phosphatidylcholine |
B |
A |
|
|
 |
3FUR |
Crystal Structure of PPARg in complex with INT131 |
H |
A |
|
|
 |
3FXV |
Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist |
B |
A |
|
|
 |
3G9E |
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes |
B |
A |
|
|
 |
3GYU |
Nuclear receptor DAF-12 from parasitic nematode Strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 7 |
B |
A |
|
|
 |
3GYT |
Nuclear receptor DAF-12 from parasitic nematode Strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 4 |
B |
A |
|
|